Skip to main content

Table 2 Genotype and haplotype frequencies of SLCO polymorphisms in 53 postmenopausal patients with osteoporosis

From: Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene

SLCO variant

genotype

number of patients

frequency (%)

SLCO1B1 c.388A > G

AA

14

26.4

 

AG

28

52.8

 

GG

11

20.8

SLCO1B1 c.521T > C

TT

35

66.0

 

TC

18

34.0

 

CC

0

0

SLCO1B3 int7C > G

CC

36

67.9

 

CG

16

30.2

 

GG

1

1.9

SLCO1B1 haplotype

number haplotype copies

  

*1a (reference haplotype)

0

11

20.8

 

1

30

56.6

 

2

12

22.6

*1b (c.388A > G)

0

24

45.3

 

1

24

45.3

 

2

5

9.4

*5 (c.521T > C)

0

51

96.2

 

1

2

3.8

 

2

0

0

*15 (c.388A > G and c.521T > C)

0

37

69.8

 

1

16

30.2

 

2

0

0